ELI LILLY AND COMPANY

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Spend

$231.9M

Filings

753

Firms Hired

Active Period

1999–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	$9,618,850	30	10
2025	$22,695,000	47	10
2024	$11,880,000	36	8
2023	$9,471,360	38	9
2022	$6,806,850	35	8
2021	$8,855,000	37	9
2020	$5,420,000	30	7
2019	$9,240,000	27	6
2018	$9,880,000	27	6
2017	$12,785,000	44	10
2016	$10,540,000	45	8
2015	$6,995,000	30	7
2014	$10,356,000	33	8
2013	$13,730,000	47	11
2012	$10,946,000	40	11
2011	$9,680,000	34	8
2010	$7,460,000	37	9
2009	$11,215,000	39	9
2008	$21,100,000	48	10
2007	$4,277,220	20	8
2006	$3,700,000	9	5
2005	$3,086,890	6	4
2004	$1,480,000	3	3
2003	$2,880,000	3	3
2002	$2,960,000	3	2
2001	—	3	1
2000	$2,420,000	1	1
1999	$2,460,000	1	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
ELI LILLY AND COMPANY	$231,938,170	110
MONUMENT ADVOCACY	—	89
TARPLIN, DOWNS & YOUNG, LLC	—	43
THE MCMANUS GROUP	—	47
FOLEY HOAG LLP	—	28
VENN STRATEGIES	—	50
TIBER CREEK HEALTH STRATEGIES, INC.	—	28
THE SIMMONS & RUSSELL GROUP, LLC	—	32
INVARIANT LLC	—	31
THE NICKLES GROUP, LLC	—	27
RICCHETTI INCORPORATED	—	36
COVINGTON & BURLING LLP	—	25
FEROX STRATEGIES	—	24
TODD STRATEGY GROUP	—	17
THORN RUN PARTNERS	—	14

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	661
HOUSE OF REPRESENTATIVES	613
U.S. Trade Representative (USTR)	170
Health & Human Services, Dept of (HHS)	159
Commerce, Dept of (DOC)	150
State, Dept of (DOS)	125
Food & Drug Administration (FDA)	100
Office of Management & Budget (OMB)	81
Agriculture, Dept of (USDA)	55
Homeland Security, Dept of (DHS)	52
Justice, Dept of (DOJ)	43
Executive Office of the President (EOP)	42
Centers For Medicare and Medicaid Services (CMS)	40
White House Office	36
Natl Institutes of Health (NIH)	29
Patent & Trademark Office (PTO)	25
U.S. Agency for International Development (USAID)	17
Natl Security Council (NSC)	14
Treasury, Dept of	13
Health Resources & Services Administration (HRSA)	3

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	495
Medicare/Medicaid	Medicare/Medicaid	368
Trade (domestic/foreign)	Trade (domestic/foreign)	248
Copyright/Patent/Trademark	Copyright/Patent/Trademark	220
Pharmacy	Pharmacy	197
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	173
Consumer Issues/Safety/Products	Consumer Issues/Safety/Products	100
Foreign Relations	Foreign Relations	91
Budget/Appropriations	Budget/Appropriations	61
Agriculture	Agriculture	47
Manufacturing	Manufacturing	31
Food Industry (safety, labeling, etc.)	Food Industry (safety, labeling, etc.)	30
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	26
Torts	Torts	23
Advertising	Advertising	18
Immigration	Immigration	17
Animals	Animals	15
Government Issues	Government Issues	8
Financial Institutions/Investments/Securities	Financial Institutions/Investments/Securities	6
Science/Technology	Science/Technology	6

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 5376119th Congress

Impacts and Outcomes for Health Career Training Act

2026 · third_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Patient protection; Pharmaceutical supply chain issues and shortages; Drug pricing, coverage, value, access and quality; Transparency; Intellectual property; Health insurance accessibility; Implementation of the "Inflation Reduction Act" (HR.5376); Prescription drug approval; Policy matters related to Artificial Intelligence in health care; clinical trial reforms; FDA policy issues

Client expense: $2,590,000 · Firm income: —

Matched citations: HR.5376

H.R. 5376119th Congress

Impacts and Outcomes for Health Career Training Act

2026 · third_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Intellectual property; 340B Program; Medicare & Medicaid prescription drug diagnosis and screening reimbursement pricing, coverage, value and access; Implementation of the "Inflation Reduction Act" (HR.5376); CMS National Coverage Determination on Alzheimer's disease

Client expense: $2,590,000 · Firm income: —

Matched citations: HR.5376

H.R. 5376119th Congress

Impacts and Outcomes for Health Career Training Act

2026 · second_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Intellectual property; 340B Program; Medicare & Medicaid prescription drug diagnosis and screening reimbursement pricing, coverage, value and access; Implementation of the "Inflation Reduction Act" (HR.5376); CMS National Coverage Determination on Alzheimer's disease

Client expense: $3,258,850 · Firm income: —

Matched citations: HR.5376

H.R. 5376119th Congress

Impacts and Outcomes for Health Career Training Act

2026 · second_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Patient protection; Pharmaceutical supply chain issues and shortages; Drug pricing, coverage, value, access and quality; Transparency; Intellectual property; Health insurance accessibility; Implementation of the "Inflation Reduction Act" (HR.5376); Prescription drug approval; Policy matters related to Artificial Intelligence in health care

Client expense: $3,258,850 · Firm income: —

Matched citations: HR.5376

Show 21 more cited filings

H.R. 5376119th Congress

Impacts and Outcomes for Health Career Training Act

2026 · first_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Patient protection; Pharmaceutical supply chain issues and shortages; Drug pricing, coverage, value, access and quality; Transparency; Intellectual property; Health insurance accessibility; Implementation of the "Inflation Reduction Act" (HR.5376); Prescription drug approval; Policy matters related to Artificial Intelligence in health care

Client expense: $3,770,000 · Firm income: —

Matched citations: HR.5376

H.R. 5376119th Congress

Impacts and Outcomes for Health Career Training Act

2026 · first_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Intellectual property; 340B Program; Medicare & Medicaid prescription drug diagnosis and screening reimbursement pricing, coverage, value and access; Implementation of the "Inflation Reduction Act" (HR.5376); CMS National Coverage Determination on Alzheimer's disease

Client expense: $3,770,000 · Firm income: —

Matched citations: HR.5376

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · fourth_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Patient protection; Pharmaceutical supply chain issues and shortages; Drug pricing, coverage, value, access and quality; Transparency; Intellectual property; Health insurance accessibility; Implementation of the "Inflation Reduction Act" (HR.5376); Prescription drug approval; Policy matters related to Artificial Intelligence in health care; One Big Beautiful Bill Act (HR.1)

Client expense: $2,200,000 · Firm income: —

Matched citations: HR.1

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · fourth_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Implementation and extension of the Tax Cuts and Jobs Act; Domestic manufacturing tax incentives; Expensing of research and development costs; Global minimum tax; Pension and retirement benefit issues; round-tripping; One Big Beautiful Bill Act (HR.1)

Client expense: $2,200,000 · Firm income: —

Matched citations: HR.1

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · fourth_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Intellectual property; 340B Program; Medicare & Medicaid prescription drug reimbursement pricing, coverage, value and access; Implementation of the "Inflation Reduction Act" (HR.5376); CMS National Coverage Determination on Alzheimer's disease; One Big Beautiful Bill Act (HR.1)

Client expense: $2,200,000 · Firm income: —

Matched citations: HR.1

H.R. 5376119th Congress

Impacts and Outcomes for Health Career Training Act

2025 · fourth_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Patient protection; Pharmaceutical supply chain issues and shortages; Drug pricing, coverage, value, access and quality; Transparency; Intellectual property; Health insurance accessibility; Implementation of the "Inflation Reduction Act" (HR.5376); Prescription drug approval; Policy matters related to Artificial Intelligence in health care; One Big Beautiful Bill Act (HR.1)

Client expense: $2,200,000 · Firm income: —

Matched citations: HR.5376

H.R. 5376119th Congress

Impacts and Outcomes for Health Career Training Act

2025 · fourth_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Intellectual property; 340B Program; Medicare & Medicaid prescription drug reimbursement pricing, coverage, value and access; Implementation of the "Inflation Reduction Act" (HR.5376); CMS National Coverage Determination on Alzheimer's disease; One Big Beautiful Bill Act (HR.1)

Client expense: $2,200,000 · Firm income: —

Matched citations: HR.5376

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · second_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Patient protection; Pharmaceutical supply chain issues and shortages; Drug pricing, coverage, value, access and quality; Transparency; Intellectual property; Health insurance accessibility; Implementation of the "Inflation Reduction Act" (HR.5376); Prescription drug approval; Policy matters related to Artificial Intelligence in health care; One Big Beautiful Bill Act (HR.1)

Client expense: $2,700,000 · Firm income: —

Matched citations: HR.1

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · second_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Intellectual property; 340B Program; Medicare & Medicaid prescription drug reimbursement pricing, coverage and value; Implementation of the "Inflation Reduction Act" (HR.5376); CMS National Coverage Determination on Alzheimer's disease; One Big Beautiful Bill Act (HR.1)

Client expense: $2,700,000 · Firm income: —

Matched citations: HR.1

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · second_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Implementation and extension of the Tax Cuts and Jobs Act; Domestic manufacturing tax incentives; Expensing of research and development costs; Global minimum tax; Pension and retirement benefit issues; round-tripping; One Big Beautiful Bill Act (HR.1)

Client expense: $2,700,000 · Firm income: —

Matched citations: HR.1

H.R. 5376119th Congress

Impacts and Outcomes for Health Career Training Act

2025 · second_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Intellectual property; 340B Program; Medicare & Medicaid prescription drug reimbursement pricing, coverage and value; Implementation of the "Inflation Reduction Act" (HR.5376); CMS National Coverage Determination on Alzheimer's disease; One Big Beautiful Bill Act (HR.1)

Client expense: $2,700,000 · Firm income: —

Matched citations: HR.5376

H.R. 5376119th Congress

Impacts and Outcomes for Health Career Training Act

2025 · second_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Patient protection; Pharmaceutical supply chain issues and shortages; Drug pricing, coverage, value, access and quality; Transparency; Intellectual property; Health insurance accessibility; Implementation of the "Inflation Reduction Act" (HR.5376); Prescription drug approval; Policy matters related to Artificial Intelligence in health care; One Big Beautiful Bill Act (HR.1)

Client expense: $2,700,000 · Firm income: —

Matched citations: HR.5376

H.R. 5376119th Congress

Impacts and Outcomes for Health Career Training Act

2025 · first_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Patient protection; Pharmaceutical supply chain issues and shortages; Drug pricing, coverage, value, access and quality; Transparency; Intellectual property; Health insurance accessibility; Implementation of the "Inflation Reduction Act" (HR.5376); Prescription drug approval; Policy matters related to Artificial Intelligence in health care

Client expense: $3,350,000 · Firm income: —

Matched citations: HR.5376

H.R. 5376119th Congress

Impacts and Outcomes for Health Career Training Act

2025 · first_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Intellectual property; 340B Program; Medicare & Medicaid prescription drug reimbursement, coverage and value; Implementation of the "Inflation Reduction Act" (HR.5376); CMS National Coverage Determination on Alzheimer's disease

Client expense: $3,350,000 · Firm income: —

Matched citations: HR.5376

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · third_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Patient protection; Pharmaceutical supply chain issues and shortages; Drug pricing, coverage, value, access and quality; Transparency; Intellectual property; Health insurance accessibility; Implementation of the "Inflation Reduction Act" (HR.5376); Prescription drug approval; Policy matters related to Artificial Intelligence in health care; One Big Beautiful Bill Act (HR.1)

Client expense: $2,345,000 · Firm income: —

Matched citations: HR.1

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · third_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Implementation and extension of the Tax Cuts and Jobs Act; Domestic manufacturing tax incentives; Expensing of research and development costs; Global minimum tax; Pension and retirement benefit issues; round-tripping; One Big Beautiful Bill Act (HR.1)

Client expense: $2,345,000 · Firm income: —

Matched citations: HR.1

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · third_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Intellectual property; 340B Program; Medicare & Medicaid prescription drug reimbursement pricing, coverage, value and access; Implementation of the "Inflation Reduction Act" (HR.5376); CMS National Coverage Determination on Alzheimer's disease; One Big Beautiful Bill Act (HR.1)

Client expense: $2,345,000 · Firm income: —

Matched citations: HR.1

H.R. 5376119th Congress

Impacts and Outcomes for Health Career Training Act

2025 · third_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Intellectual property; 340B Program; Medicare & Medicaid prescription drug reimbursement pricing, coverage, value and access; Implementation of the "Inflation Reduction Act" (HR.5376); CMS National Coverage Determination on Alzheimer's disease; One Big Beautiful Bill Act (HR.1)

Client expense: $2,345,000 · Firm income: —

Matched citations: HR.5376

H.R. 5376119th Congress

Impacts and Outcomes for Health Career Training Act

2025 · third_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Patient protection; Pharmaceutical supply chain issues and shortages; Drug pricing, coverage, value, access and quality; Transparency; Intellectual property; Health insurance accessibility; Implementation of the "Inflation Reduction Act" (HR.5376); Prescription drug approval; Policy matters related to Artificial Intelligence in health care; One Big Beautiful Bill Act (HR.1)

Client expense: $2,345,000 · Firm income: —

Matched citations: HR.5376

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · second_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Patient protection; Pharmaceutical supply chain issues and shortages; Drug pricing, coverage, value, access and quality; Transparency; Intellectual property; Health insurance accessibility; Implementation of the "Inflation Reduction Act" (HR.5376); Prescription drug approval; Policy matters related to Artificial Intelligence in health care; One Big Beautiful Bill Act (HR.1)

Client expense: $2,700,000 · Firm income: —

Matched citations: HR.1

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · second_quarter · Firm: ELI LILLY AND COMPANY

Open original LDA filing ↗

Cited source text and reported amounts

Intellectual property; 340B Program; Medicare & Medicaid prescription drug reimbursement pricing, coverage and value; Implementation of the "Inflation Reduction Act" (HR.5376); CMS National Coverage Determination on Alzheimer's disease; One Big Beautiful Bill Act (HR.1)

Client expense: $2,700,000 · Firm income: —

Matched citations: HR.1

Source: Senate LDA

ELI LILLY AND COMPANY — Lobbying Disclosure | Poliscope